Page last updated: 2024-08-17

egtazic acid and globotriaosylceramide

egtazic acid has been researched along with globotriaosylceramide in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Capoulade, C; Carlier, K; Coulaud, D; Lécluse, Y; Mangeney, M; Mishal, Z; Pritchard, LL; Taga, S; Tétaud, C; Tursz, T; Wiels, J1
Huang, J; Liu, F; Sadler, JE1

Other Studies

2 other study(ies) available for egtazic acid and globotriaosylceramide

ArticleYear
Intracellular signaling events in CD77-mediated apoptosis of Burkitt's lymphoma cells.
    Blood, 1997, Oct-01, Volume: 90, Issue:7

    Topics: Apoptosis; Burkitt Lymphoma; Calcium; Calcium Channels; Ceramides; Chelating Agents; Colforsin; Cyclic AMP; Egtazic Acid; Humans; Ion Transport; Ionophores; Signal Transduction; Trihexosylceramides; Tumor Cells, Cultured

1997
Shiga toxin (Stx)1B and Stx2B induce von Willebrand factor secretion from human umbilical vein endothelial cells through different signaling pathways.
    Blood, 2011, Sep-22, Volume: 118, Issue:12

    Topics: Animals; Calcium; Cyclic AMP-Dependent Protein Kinases; Diarrhea; Egtazic Acid; Endothelial Cells; Escherichia coli; Escherichia coli Infections; Gene Silencing; Hemolytic-Uremic Syndrome; Humans; Mice; Protein Binding; Protein Kinase C-alpha; Protein Kinase Inhibitors; RNA, Small Interfering; Shiga Toxin 1; Shiga Toxin 2; Signal Transduction; Trihexosylceramides; Umbilical Veins; von Willebrand Factor

2011